Eurofins Discovery built its industry-leading reputation on successfully delivering best-in-class drug discovery outsourcing services to any organization, large or small. No matter where you are in the preclinical process—or if you need full end-to-end solutions—our experts support you every step of the way with purpose, precision, and innovation.

As a global leader in drug discovery for over 40 years, we have strategically curated a deep and broad range of over 8,000 assays and related services covering chemistry, safety & efficacy, mechanism-of-action, ADME-toxicology, and translational biology. Our team of industry experts for in vitro and in vivo services, GPCRs, and custom protein and assay development work across disciplines to collaborate with you. Eurofins Discovery’s comprehensive capabilities, knowledge base, and skill sets enable the company to provide clients the benefit of working with a single outsourcing provider (CRO) for all drug discovery programs.

Delve into all the ways we can work together by choosing the best path forward for you from our comprehensive services.

Eurofins Discovery has developed a panel of novel LeadHunter® Src Homology 2 (SH2) domain binding assays targeting Signal Transducer and Activation of Transcription (STAT) proteins (STAT1, STAT2, STAT3, STAT4, STAT5A, STAT5B and STAT6). For more information please visit https://www.eurofinsdiscovery.com/solution/stat-profiling